Caffeic acid, but not ferulic acid, inhibits macrophage pyroptosis by directly blocking gasdermin D activation
- MedComm (2020). 2023 Apr 20;4(3):e255. doi: 10.1002/mco2.255.
- 1. Beijing Key Laboratory of Basic Research With Traditional Chinese Medicine on Infectious Diseases Beijing Hospital of Traditional Chinese Medicine Capital Medical University Beijing China.
- 2. College of Veterinary Medicine Yangzhou University Yangzhou China.
- 3. Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses Yangzhou China.
- 4. Beijing University of Chemical Technology Beijing China.
- 5. Beijing Chest Hospital Capital Medical University Beijing China.
Regulated Pyroptosis is critical for pathogen elimination by inducing infected cell rupture and pro-inflammatory cytokines secretion, while overwhelmed Pyroptosis contributes to organ dysfunction and pathological inflammatory response. Caffeic acid (CA) and ferulic acid (FA) are both well-known antioxidant and anti-inflammatory phenolic acids, which resemble in chemical structure. Here we found that CA, but not FA, protects macrophages from both Nigericin-induced canonical and cytosolic lipopolysaccharide (LPS)-induced non-canonical Pyroptosis and alleviates LPS-induced mice sepsis. It significantly improved the survival of pyroptotic cells and LPS-challenged mice and blocked proinflammatory cytokine secretion. The anti-pyroptotic effect of CA is independent of its regulations in cellular lipid peroxidation, mitochondrial function, or pyroptosis-associated gene transcription. Instead, CA arrests Pyroptosis by directly associating with gasdermin D (GSDMD) and blocking its processing, resulting in reduced N-GSDMD pore construction and less cellular content release. In LPS-induced septic mice, CA inhibits GSDMD activation in peritoneal macrophages and reduces the serum levels of interleukin-1β and tumor necrosis factor-α as the known Pyroptosis inhibitors, disulfiram and dimethyl fumarate. Collectively, these findings suggest that CA inhibits Pyroptosis by targeting GSDMD and is a potential candidate for curbing the pyroptosis-associated disease.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Metabolic Disease